1. E-learning within the European cystic fibrosis society - A multidisciplinary cross-sectional survey.
- Author
-
Smith C, Chadwick HK, Hill K, and Peckham DG
- Subjects
- Humans, Cross-Sectional Studies, Europe, Surveys and Questionnaires, Education, Medical, Continuing methods, Education, Distance methods, Cystic Fibrosis therapy, Societies, Medical
- Abstract
Background: Continuing professional development (CPD) is a component of practice that spans all disciplines within cystic fibrosis (CF). E-learning resources theoretically represent flexible, low cost and time efficient methods of CPD. We aimed to explore European Cystic Fibrosis Society (ECFS) members' and CF health professional communities' current views, experiences and perceptions of e-learning and the ECFS education platform (ECFS-EP)., Methods: An online cross-sectional survey was developed by the ECFS Education Committee and circulated via the ECFS conference, emails and within the society subgroups between June and September 2023., Results: 547 responses were received from 58 countries; 57 % of responders were ECFS members. A wide range of specialities were represented from the multidisciplinary team including 36 % clinicians. The majority of respondents (63 %) spent 6 or more hours a week on their professional education. Online platforms were used either weekly (34 %) or monthly (37 %); 54 % of respondents had used the ECFS-EP and this was rated favourably overall, specifically for content quality. Preferred formats for education were articles and medium length (15-30 min) webinars., Conclusions: This multidisciplinary cohort survey illustrates contemporary practice and opinion relating to e-learning and the ECFS-EP. Strengths include the high number of responses and the wide range of countries and specialities represented. Results suggest the ECFS-EP is valued and highlights priority topics, preferred formats and opportunities to optimise awareness. Results support continued provision and oversight of high quality education via an online platform. Continued success will rely on learning from user experience and feedback to inform future practice., Competing Interests: Declaration of competing interest CS: Has received advisory fees from Vertex Pharmaceuticals and Nordic Pharma and speaker fees from Vertex Pharmaceuticals HKC: Reports no conflict of interest KH: Reports no conflicts of interest DP: Has received speaker/board honoraria from Vertex Pharmaceuticals, (Copyright © 2024. Published by Elsevier B.V.)
- Published
- 2024
- Full Text
- View/download PDF